Abstract:Human serum albumin (HSA), the most abundant plasma protein in human blood, is a natural transport vehicle with multiple ligand binding sites. It, therefore, constitutes an attractive candidate for drug delivery. Targeting may occur via the most known interaction of the protein with the neonatal Fc receptor (FcRn). Here, we investigate another HSA delivery path, involving the transferrin receptor, and we elaborate a maghemite-HSA nanohybrid, opening up new opportunities for medical applications. Fluorescence spectrophotometric titration and size-exclusion chromatography were used to substantiate, in cell-free assays, an interaction between HSA and the transferrin receptor R1. This occurs with a dissociation constant, KD of 6.7 nM. This interaction was confirmed in HeLa cell culture where, by confocal microscopy, rhodamine-labeled HSA is shown to be internalized. HSA was then covalently conjugated onto maghemite nanoparticles (NPs) to give a NP-HSA nanohybrid. The therapeutic potential of this hybrid was demonstrated through its heating capacity in magnetic hyperthermia (MH) and near-infrared (NIR) photothermia (PT). In particular, the Specific Absorption Rate (SAR) in the PT Therapy (PTT) mode, using a 808 nm NIR-LASER (1 W cm-2) and at iron concentration as low as 2.5 mM, was found to be very high, equal to 1870 W g-1 with a temperature increment of 9.2 °C. The nanohybrids incubated with HeLa cells were mainly localized at the cell surface. When the PTT mode was applied under the same conditions as in vitro, mortality was higher in HeLa cells than in fibroblasts (non-malignant cells). Cytotoxicity was checked in both cell lines without the PTT mode; the nanohybrids do not seem to affect cell viability. These results make the nanohybrids very promising agents for NIR-PT and for targeting in cancer therapy, since non-malignant cells were not damaged.

Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging

PET/NIRF/MRI triple functional iron oxide nanoparticles.

Serum Albumin for Magnetic Nanoparticles Coating

Albumin covering maintains endothelial function upon magnetic iron oxide nanoparticles intravenous injection in rats

Maghemite Nanoparticles Coated with Human Serum Albumin: Combining Targeting by the Iron-Acquisition Pathway and Potential in Photothermal Therapies

Biomineralized Iron Oxide-Polydopamine Hybrid Nanodots for Contrast-Enhanced T1-weighted Magnetic Resonance Imaging and Photothermal Tumor Ablation.

Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level

Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shell

Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy

Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia.

Synthesis, Principles, and Properties of Magnetite Nanoparticles for In Vivo Imaging Applications—A Review

Albumin Nanoreactor-Templated Synthesis of Gd2O3/CuS Hybrid Nanodots for Cancer Theranostics

Heparin–Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications

Intelligent Albumin-Stabilized Manganese Dioxide Nanocomposites for Tumor Microenvironment Responsive Phototherapy

Advancements in Iron Oxide Nanoparticles for Multimodal Imaging and Tumor Theranostics

Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy

Human Serum Albumin Coated Iron Oxide Nanoparticles For Efficient Cell Labeling

Long-Circulating Iodinated Albumin-Gadolinium Nanoparticles As Enhanced Magnetic Resonance and Computed Tomography Imaging Probes For. Osteosarcoma Visualization

Manganese Doped Iron Oxide Theranostic Nanoparticles for Combined T-1 Magnetic Resonance Imaging and Photothermal Therapy

Biosensors and Drug Delivery in Oncotheranostics Using Inorganic Synthetic and Biogenic Magnetic Nanoparticles